Shengxian Li

2.6k total citations
95 papers, 1.9k citations indexed

About

Shengxian Li is a scholar working on Reproductive Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Shengxian Li has authored 95 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Reproductive Medicine, 17 papers in Molecular Biology and 17 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Shengxian Li's work include Ovarian function and disorders (19 papers), Nanoplatforms for cancer theranostics (9 papers) and Reproductive Biology and Fertility (8 papers). Shengxian Li is often cited by papers focused on Ovarian function and disorders (19 papers), Nanoplatforms for cancer theranostics (9 papers) and Reproductive Biology and Fertility (8 papers). Shengxian Li collaborates with scholars based in China, United States and New Zealand. Shengxian Li's co-authors include Tao Tao, Jixue Wang, Xin‐Gui Li, Yong Huang, Chunxi Wang, Mei‐Rong Huang, Rong Huang, Yun Sun, Jianxun Ding and Jing Ma and has published in prestigious journals such as PLoS ONE, Advanced Functional Materials and Analytical Chemistry.

In The Last Decade

Shengxian Li

88 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengxian Li China 25 469 372 325 263 236 95 1.9k
Giovanni Luca Italy 28 637 1.4× 449 1.2× 339 1.0× 515 2.0× 226 1.0× 121 3.0k
Xin Zeng China 22 739 1.6× 296 0.8× 751 2.3× 102 0.4× 533 2.3× 67 2.5k
Sung Won Lee South Korea 31 419 0.9× 188 0.5× 299 0.9× 844 3.2× 522 2.2× 179 3.6k
Huiping Zhang China 21 290 0.6× 260 0.7× 133 0.4× 47 0.2× 55 0.2× 98 1.5k
Kang Sun China 37 724 1.5× 203 0.5× 170 0.5× 538 2.0× 40 0.2× 174 3.9k
Yulong Zhang China 26 404 0.9× 70 0.2× 195 0.6× 60 0.2× 75 0.3× 117 2.2k
Tiantian Zhu China 22 353 0.8× 139 0.4× 109 0.3× 85 0.3× 48 0.2× 86 1.3k
Xiaoyan Lv China 28 1.3k 2.7× 51 0.1× 743 2.3× 347 1.3× 252 1.1× 96 3.2k

Countries citing papers authored by Shengxian Li

Since Specialization
Citations

This map shows the geographic impact of Shengxian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengxian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengxian Li more than expected).

Fields of papers citing papers by Shengxian Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengxian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengxian Li. The network helps show where Shengxian Li may publish in the future.

Co-authorship network of co-authors of Shengxian Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shengxian Li. A scholar is included among the top collaborators of Shengxian Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengxian Li. Shengxian Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Junyao, Zi Li, Qiang Zhao, et al.. (2025). Dietary sulfur amino acid restriction improves metabolic health by reducing fat mass. PubMed. 4(3). loaf009–loaf009.
2.
Xu, Yuanzhi, et al.. (2025). Photodynamic therapy for the precise treatment of localized prostate cancer. Frontiers in Oncology. 15. 1454392–1454392. 2 indexed citations
3.
Li, Shengxian, et al.. (2025). Novel technologies, effects and applications of modified plant proteins by Maillard reaction and strategies for regulation: A review. Food Research International. 204. 115959–115959. 4 indexed citations
4.
5.
6.
Li, Shengxian, Dong Si, Jing Wu, et al.. (2023). Surgically Derived Cancer Cell Membrane-Coated R837-Loaded Poly(2-Oxazoline) Nanoparticles for Prostate Cancer Immunotherapy. ACS Applied Materials & Interfaces. 15(6). 7878–7886. 25 indexed citations
7.
Li, Shuang, Shengxian Li, & Man Shi. (2022). A Compact Wideband Bandpass Filter With Tunable Notched Band. 2022 International Conference on Microwave and Millimeter Wave Technology (ICMMT). pp. 1–3. 1 indexed citations
8.
Wang, Hanzhou, Shengxian Li, Yuyang Sun, et al.. (2022). Organ-specific extracellular matrix directs trans-differentiation of mesenchymal stem cells and formation of salivary gland-like organoids in vivo. Stem Cell Research & Therapy. 13(1). 306–306. 9 indexed citations
9.
Liu, Weifang, et al.. (2022). Overexpressed LAMC2 promotes trophoblast over‐invasion through the PI3K/Akt/MMP2/9 pathway in placenta accreta spectrum. Journal of obstetrics and gynaecology research. 49(2). 548–559. 13 indexed citations
10.
Zhang, Ruirui, et al.. (2021). PLGA-based drug delivery system for combined therapy of cancer: research progress. Materials Research Express. 8(12). 122002–122002. 26 indexed citations
11.
Yue, Jiang, Hua Xu, Yong Zhou, et al.. (2021). Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study. Frontiers in Endocrinology. 12. 611526–611526. 13 indexed citations
12.
Qi, Yicheng, Wen Liu, Xiangsheng Wang, et al.. (2021). Adipose-derived mesenchymal stem cells from obese mice prevent body weight gain and hyperglycemia. Stem Cell Research & Therapy. 12(1). 277–277. 8 indexed citations
13.
Zhang, Xueqin, Shengxian Li, Zeng‐Ping Chen, Yao Chen, & Ru‐Qin Yu. (2018). Quantitative SERS analysis based on multiple-internal-standard embedded core-shell nanoparticles and spectral shape deformation quantitative theory. Chemometrics and Intelligent Laboratory Systems. 177. 47–54. 20 indexed citations
14.
Feng, Rilu, Cheng Qian, Qianjing Liu, et al.. (2017). Expression of sweet taste receptor and gut hormone secretion in modelled type 2 diabetes. General and Comparative Endocrinology. 252. 142–149. 14 indexed citations
15.
Li, Shengxian, Jing Ma, Yun Sun, et al.. (2017). A pilot study of the opposing effects of hyperinsulinemia and hyperandrogenenism on serum lipid profiles and bioactive lipids in women with polycystic ovary syndrome. Zhonghua neifenmi daixie zazhi. 33(8). 644–650. 1 indexed citations
16.
Li, Shengxian, Jing Ma, Yun Sun, et al.. (2016). Discovery of novel lipid profiles in PCOS: Do insulin and androgen oppositely regulate bioactive lipid production?. The Journal of Clinical Endocrinology & Metabolism. 102(3). jc.2016–2692. 67 indexed citations
17.
Huang, Rong, Jiang Yue, Yun Sun, et al.. (2015). Increased serum chemerin concentrations in patients with polycystic ovary syndrome: Relationship between insulin resistance and ovarian volume. Clinica Chimica Acta. 450. 366–369. 34 indexed citations
18.
Ping, Zhang, Xiangyu Teng, Lihua Wang, et al.. (2013). The prevalence of polyocystic ovary syndrome in nurses of reproductive age. Zhonghua neifenmi daixie zazhi. 29(3). 206–210. 1 indexed citations
19.
Tao, Tao, Wei Liu, Aimin Zhao, et al.. (2013). Morbidity and risk factors of metabolic syndrome in different phenotypes of polycystic ovary syndrome. Zhonghua neifenmi daixie zazhi. 29(3). 200–205. 1 indexed citations
20.
Li, Xuesong, Lijing Shao, Z. Wu, et al.. (2008). Influence of visceral adiposity on ghrelin secretion and expression in rats during fasting. Journal of Molecular Endocrinology. 42(1). 67–74. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni Luca Breakdown of academic impact, for papers by Xin Zeng Breakdown of academic impact, for papers by Sung Won Lee Breakdown of academic impact, for papers by Huiping Zhang Breakdown of academic impact, for papers by Kang Sun Breakdown of academic impact, for papers by Yulong Zhang Breakdown of academic impact, for papers by Tiantian Zhu Breakdown of academic impact, for papers by Xiaoyan Lv
Rankless by CCL
2026